Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Levetiracetam
Medication labelLevetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Levetiracetam is indicated as…
Why this: Advisory · dailymed-prescription
Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Levetiracetam is indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy. Levetiracetam is indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.
- generic_name
- levetiracetam
- product_names
- Levetiracetam
- ndc
- 51672-4141, 51672-4142, 51672-4143, 51672-4137, 51672-4136, 51672-4141-6, 51672-4141-1, 51672-4141-3, 51672-4141-0, 51672-4142-6, 51672-4142-1, 51672-4142-3, 51672-4142-0, 51672-4143-6, 51672-4143-1, 51672-4143-3, 51672-4143-0, 51672-4137-6, 51672-4137-4, 51672-4137-8, 51672-4136-7, 51672-4136-9, 51672-4136-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en